04/26/2024 4:22 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:57 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:59 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:01 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:05 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/19/2024 5:06 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:18 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:14 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:16 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:54 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:31 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:34 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:37 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:39 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:44 PM | Immunovant (Issuer) Torti Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:46 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:48 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:50 PM | Hughes Douglas J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:23 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:29 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:14 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:21 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 AM | Deep Track Capital, LP (Filed by) Immunovant (Subject)
| Form SC 13G/A | |
02/12/2024 6:02 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:05 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/09/2024 8:16 AM | Immunovant (Subject)
| Form SC 13G | |
01/19/2024 3:04 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:29 AM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/12/2024 3:34 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:18 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:20 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:08 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:37 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:25 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:28 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:30 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Claim Your Complimentary Bitcoin Reward (Ad) Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you?
In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants.
Absolutely no strings attached. Secure Your Spot Now |
12/01/2023 3:19 PM | Immunovant (Subject) MIGAUSKY GEORGE V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:19 PM | Fromkin Andrew J. (Reporting) Immunovant (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:20 PM | Immunovant (Subject) Pande Atul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023 6:43 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 1:55 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:45 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:47 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:51 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:41 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 7:49 AM | Immunovant (Filer)
| Form S-3ASR | |
11/09/2023 6:06 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:13 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023 3:06 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 3:11 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:10 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:15 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:15 PM | Immunovant (Issuer) Roivant Sciences Ltd. (Reporting) Roivant Sciences Ltd. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:19 PM | Immunovant (Subject) Roivant Sciences Ltd. (Filed by) Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A | |
09/29/2023 3:48 PM | Immunovant (Filer)
| Form 424B5 | |
09/28/2023 4:23 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 5:09 AM | Immunovant (Subject)
| Form FWP | |
09/26/2023 7:00 PM | Immunovant (Subject)
| Form FWP | |
09/26/2023 4:28 PM | Immunovant (Filer)
| Form 424B5 | |
09/26/2023 6:45 AM | Immunovant (Filer) Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:00 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:03 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:05 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:57 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:48 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 3:11 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:19 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:10 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 3:35 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/20/2023 3:37 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 4:10 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 4:11 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:35 AM | Immunovant (Filer)
| Form DEFA14A | |
06/26/2023 6:26 AM | Immunovant (Filer)
| Form DEF 14A | |
05/22/2023 6:03 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2023 6:10 AM | Immunovant (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |